Tag Archives: Alzheimer’s Disease
New Delhi: In a groundbreaking study, scientists at the All India Institute of Medical Sciences (AIIMS), New Delhi have described a new type of diabetes they term as “Diabetes Type 4”. This new discovery is expected to open a new field of therapy for glaucoma and neurodegenerative diseases.
Washington: Dr Sudha Seshadri, professor of neurology at Boston University School of Medicine (BUSM), has been awarded three grants this year totalling nearly $20 million from the National Institute on Aging (NIA) and the National Institute of Neurological Disorders and Stroke (NINDS).
New York: A component of aspirin can block a cell death associated with neurodegenerative diseases like Alzheimer’s, Parkinson’s and Huntington’s disease, a new study says.
London: The brain cannot be palpated without using a highly invasive procedure, but researchers have now developed a noninvasive brain imaging method using magnetic resonance imaging (MRI) that provides the same information as physical palpation.
Washington: Alzheimer’s disease, long thought to be a single disease, really consists of three distinct subtypes, according to a UCLA study. The finding could lead to more highly targeted research and, eventually, new treatments for the debilitating neurological disorder, which robs people of their memories.
Recently, on unfolding Hindustan Times, I noticed a headline to a column that went on to elaborate that India has the third highest number of dementia patients. Professor Prince of London who made this claim is one of the world leaders in neuroscience research.
Mumbai: In a major breakthrough, Indian scientists have managed to get a glimpse of the protein fragments known as amyloid beta, which hallmark Alzheimer’s disease.
Washington: New UCLA research indicates that lost memories can be restored. The findings offer some hope for patients in the early stages of Alzheimer’s disease.
Varanasi: Researchers at the Institute of Medical Sciences, Banaras Hindu University (IMS-BHU) have identified RhoA as a novel drug target in the treatment of Alzheimer’s disease. The study has been published in the FASEB Journal.